يعرض 1 - 10 نتائج من 453 نتيجة بحث عن '"Kohn, Elise C"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المصدر: Obstetrical & Gynecological Survey ; volume 79, issue 4, page 213-215 ; ISSN 1533-9866 0029-7828

  3. 3
  4. 4
    دورية أكاديمية

    المصدر: Vergote , I , Gonzalez-Martin , A , participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research , Lorusso , D , Gourley , C , Mirza , M R , Kurtz , J E , Okamoto , A , Moore , K , Kridelka , F , McNeish , I , Reuss , A , Votan , B , du Bois , A , Mahner , S , Ray-Coquard , I , Kohn , E C , Berek , J S , Tan , D S P , Colombo , N , ....

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Journal of Vascular and Interventional Radiology. 24(8)

    وصف الملف: application/pdf

  7. 7
    دورية أكاديمية

    المساهمون: Research Program in Systems Oncology, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics

    وصف الملف: application/pdf

    العلاقة: We thank the patients and their families for their participation in this study. This study was funded by the NCI-Cancer Therapy Evaluation Program (CTEP) and conducted under the auspices of the Experimental Therapeutics Clinical Trials Network (ETCTN). Dana-Farber/Harvard Cancer Center served as the lead site for the study, supported by NIH grant UM1 CA186709 (G.I.S., Principal Investigator). This work was also funded by Supplements to UM1 CA186709 for the development of immunohistochemical biomarkers for homologous recombination repair and ATM proficiency (B.K., A.D.D., and G.I.S.) and by the Dana-Farber/Harvard Cancer Center Specialized Program of Research Excellence (SPORE) (P50CA240243) in Ovarian Cancer (P.A.K., B.K., J.F.L., N.T., U.A.M., A.D.D., and G.I.S.).; Konstantinopoulos , P A , da Costa , A A B A , Gulhan , D , Lee , E K , Cheng , S-C , Hendrickson , A E W , Kochupurakkal , B , Kolin , D L , Kohn , E C , Liu , J F , Stover , E H , Curtis , J , Tayob , N , Polak , M , Chowdhury , D , Matulonis , U A , Färkkilä , A , D'Andrea , A D & Shapiro , G 2021 , ' A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer ' , Nature Communications , vol. 12 , no. 1 , 5574 . https://doi.org/10.1038/s41467-021-25904-wTest; e0d06ff9-4e70-47ca-bbac-1162e2726c17; http://hdl.handle.net/10138/336193Test; 000700360600009

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المساهمون: Australian Government Research Training Program

    المصدر: Cancer ; volume 126, issue 10, page 2139-2145 ; ISSN 0008-543X 1097-0142